Clinical Trials Logo

Cerebral Palsy clinical trials

View clinical trials related to Cerebral Palsy.

Filter by:

NCT ID: NCT05657548 Recruiting - Clinical trials for Cerebral Palsy Infantile

Study of Sagittal Pelvic Statics in the Sitting Position in Children With Cerebral Palsy

SPS-PC
Start date: October 30, 2023
Phase:
Study type: Observational

Cerebral palsy is the leading cause of motor disability in children. Children with little or no walking (GMFCS III, IV and V) represent 43% of children with cerebral palsy, the majority of whom present pelvic and spinal deformities in the frontal and sagittal planes. However, sagittal pelvic spinal statics have been little studied, especially in the sitting position, which is the functional position of these children. Moreover, there are currently no recommendations on how to perform follow-up radiographs of the spine in children who do not walk much. A better understanding of pelvic and sagittal spinal statics would help prevent deformities and their complications. Standardizing the method of performing pelvic-spinal radiographs in the sitting position will make monitoring of spinal statics more reliable.

NCT ID: NCT05655572 Recruiting - Clinical trials for Diplegic Cerebral Palsy

Comparison Between AOT and Functional Training on Balance, Mobility and Cognition in Diplegic Cerebral Palsy

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to find out the effects of Action observation therapy as compared to the traditional physiotherapy in diplegic spastic cerebral palsy patients. We will check the effects on balance mobility and cognition of patients.

NCT ID: NCT05650593 Recruiting - Cerebral Palsy Clinical Trials

Oral Health Status in a Group of Egyptian Children With Cerebral Palsy: A Cross-sectional Study

Start date: October 6, 2022
Phase:
Study type: Observational

The aim of the study is to assess the oral health status in a group of Egyptian children with cerebral palsy.

NCT ID: NCT05649930 Recruiting - Clinical trials for Cerebral Palsy, Spastic

Effect of Functional Power Training on Calf Muscle Length and Strength in Children With Spastic Paresis

MegaMuscle
Start date: June 20, 2022
Phase:
Study type: Observational

Spastic paresis (SP) is a common motor condition in children and is often caused by cerebral palsy. Skeletal muscles develop differently in children with SP due to brain damage in early development; muscle strength and muscle length are reduced compared to typically developing (TD) children. Especially, the calf muscles are affected, which particularly affects their ability to walk and to run, hindering participation in society. There are several treatments aimed to increase the range of motion of the joint by lengthening the muscle, for example botulinum toxin injections. However, these treatments can have a weakening effect on the muscle due to deconditioning from immobilization and due to paralysis. In rehabilitation centers in the Netherlands functional power training (MegaPower) is offered to children with SP who want to walk and run better. It has been shown that this training improves calf muscle strength and performance during functional walking tests. However, the effect of MegaPower training on muscle morphology (i.a. muscle volume and length) is still unknown. Therefore, the aim of this study is to assess the effect of MegaPower training on the muscle morphology of the medial gastrocnemius in children with SP using 3D ultrasonography. It is expected that MegaPower training results in an increase of muscle volume as well as elongation of the muscle belly. Muscle volume could increase due to hypertrophy of the muscle fibers induced by the training, which could elongate the muscle belly length due to the pennate structure of the medial gastrocnemius. A double-baseline design will be applied for this study with three different measurement times (T0-T1-T2) to compare the training period (12 weeks) with a period (12 weeks) of usual care.

NCT ID: NCT05649254 Recruiting - Cerebral Palsy Clinical Trials

Effect of TENS in Children With Spastic Cerebral Palsy

Start date: November 30, 2022
Phase:
Study type: Observational

TENS is cheap and simple tool for physiotherapist, free of many side effects compared with other tools. so The aim of study was record the effect of TENS on calf muscle tone in spastic cerebral palsy children.

NCT ID: NCT05648422 Recruiting - Cerebral Palsy Clinical Trials

Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral Palsy

NSS-PC
Start date: January 16, 2023
Phase: N/A
Study type: Interventional

Study to determine the impact of a nutritional support system (NSS) on neuromotor alterations in patients with cerebral palsy.

NCT ID: NCT05645874 Recruiting - Cerebral Palsy Clinical Trials

Reference Values of Intraepidermal Nerve Fiber Density in Children and Small Fiber Neuropathy in Neurometabolic and Neurodevelopmental Disorders in Children

SFN_children
Start date: January 1, 2022
Phase:
Study type: Observational

Background: Small-Fiber-Neuropathy describes the degeneration of mildly or unmyelinated nerve fibers and causes neuropathic pain and autonomic dysfunction. Gold standard for the diagnosis is a small skin punch biopsy from the lower leg and the histological quantification of the intraepidermal nerve fiber density (IENFD). In children, the normal IENFD has not been systematically assessed and normal reference values are needed. In Parkinson´s disease, the neurodegeneration also affects the peripheral nerves and SFN is present already in the early stages. Whether neurodevelopmental disorders (NDDs) in childhood are likewise associated with SFN is largely unknown. The IENFD is age-dependent and declines with age. Aims: In this study, we are establishing the reference values for the physiological IENFD in children from 0-18 years. Moreover, we are investigating if children with NDDs have a reduced IENFD and if SNF is a clinically relevant cause of pain and autonomic dysfunction.

NCT ID: NCT05627921 Recruiting - Clinical trials for Cerebral Palsy, Spastic

The Effect of Botulinum Toxin and ESWT Applications on Spasticity and Functionality in Cerebral Palsy Patients

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

Cerebral Palsy (CP) is a group of movement and posture disorders associated with a non-progressive affect during brain development that can cause limitation of activity and disability. The most common movement disorders in CP are spasticity and dystonia. Currently, the treatment of muscle stiffness called spasticity includes physiotherapy, casting and device, various drugs and surgical treatment. Botulinum toxin injection into the muscle also acts by reducing muscle contraction. ESWT is a method used in various musculoskeletal diseases. It has been previously applied to pediatric patients and has been shown to be effective and painless in ankle muscle stiffness. However, there are few studies investigating the effect of ESWT on functionality.

NCT ID: NCT05624541 Recruiting - Cerebral Palsy Clinical Trials

Validity and Reliability of Specific Test of Early Infant Motor Performance (STEP) Version 3.0

Start date: January 18, 2022
Phase:
Study type: Observational

Cerebral palsy and other neuromotor disorders are more common in babies born preterm (<37 weeks of gestation), due to various biological and environmental risk factors and the risk increases as the gestational age decreases. Earlier and more frequent screening with the use of developmental skills tests facilitates referral to early intervention programs. Current guidelines recommend using some combination of neuroimaging and neurological examination and assessments such as neonatal imaging, general movements (GMs), and Hammersmith Infant Neurological Examination (HINE) for early diagnosis and intervention.

NCT ID: NCT05615402 Recruiting - Cerebral Palsy Clinical Trials

Intervention on Bone Health in Wheelchair Users

BoneWheel
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

The low mechanical loading of bones among wheelchair users leads to an increased risk of bone fractures and associated complications due to low bone mineral density (BMD). Adding mechanical loading through physical activity in combination with optimizing nutrition may counteract these negative consequences in wheelchair users and thereby provide positive impact for bone health, as well as for physical and mental health. In this project, a multidisciplinary team will tailor a bone-specific exercise and nutrition program to increase BMD in sport active and non-active wheelchair users with initial low BMD.